OTA 2019: IV Ibuprofen Reduces Opioid Consumption in Trauma Patients .
Intravenous Ibuprofen Reduces Opioid Consumption in Acute Pain Management for Orthopaedic Trauma Patients
Ninety-nine orthopaedic trauma patients were randomized to received either IV Ibuprofen (Caldolor) or placebo every 6 hours for 48 hours within admission. Outcomes included pain on the Numeric Rating Scale, opioid consumption, time to first narcotic administration. Interestingly, though IV Ibuprofen did not significantly affect pain scores, it did significantly reduce opioid consumption and tIme to first narcotic was significantly longer in the IV ibuprofen group compared to placebo.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics